The latest closing stock price for Iterum Therapeutics as of November 22, 2024 is 1.81.
An investor who bought $1,000 worth of Iterum Therapeutics stock at the IPO in 2018 would have $-991 today, roughly -1 times their original investment - a -54.07% compound annual growth rate over 6 years.
The all-time high Iterum Therapeutics stock closing price was 192.75 on May 25, 2018.
The Iterum Therapeutics 52-week high stock price is 2.50, which is 38.1% above the current share price.
The Iterum Therapeutics 52-week low stock price is 0.81, which is 55.2% below the current share price.
The average Iterum Therapeutics stock price for the last 52 weeks is 1.43.
An investor who bought $1,000 worth of Iterum Therapeutics stock at the IPO in 2018 would have $-991 today, roughly -1 times their original investment - a -54.07% compound annual growth rate over 6 years.
The all-time high Iterum Therapeutics stock closing price was 192.75 on May 25, 2018.
The Iterum Therapeutics 52-week high stock price is 2.50, which is 38.1% above the current share price.
The Iterum Therapeutics 52-week low stock price is 0.81, which is 55.2% below the current share price.
The average Iterum Therapeutics stock price for the last 52 weeks is 1.43.